Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
In 2023, the COVID-19 pandemic has lost some of its disruptive potency; however, analgesic sales in Azerbaijan are ticking upwards in value terms (with the exception of adult aspirin). Value sales are being pushed by Azerbaijan's reliance on imports,…
Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…
The reopened border between mainland China and Hong Kong in early 2023 had significant implications for the demand of analgesic remedies within the city, which rose considerably. This growth can be attributed to a shortage of analgesic remedies…
The driving force behind the growth of analgesics in India is the Millennial population, which includes those born between 1980 and 1994. This demographic, consisting of 328 million people, significantly drives demand for analgesics. The key reason…
In the context of transforming the health system in Indonesia, one of the agendas currently being pursued by the Ministry of Health is to increase pharmaceutical resilience by increasing domestic production of the top 10 value medicines, which…
Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a…
Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…
The return of consumers to their busy-pandemic lifestyles had a positive impact on demand for analgesics in Malaysia in 2023. Within this, topical analgesics/anaesthetic remained the largest subcategory, as well as being the key driver of growth.…
Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also…
Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the…